NF1 patients are also susceptible to various forms of cancers, including glioma of the optic pathway, gastrointestinal stromal tumors, rhabdomyosarcomas, leukemia, breast cancers, etc. [3]; development of which requires a complete loss of Nf1 gene function [4]. This evidence concerns the gene NF1 and rhabdomyosarcoma.